Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group

International Journal of Hematology

Volumn 93, Issue 1, 2011, Pages 66-73

  Yoshida, Minoru ^p   Akiyama, Nobu ^a   Fujita, Hiroyuki ^b   Miura, Katsuhiro ^c   Miyatake, Jun Ichi ^d   Handa, Hiroshi ^e   Kito, Katsuyuki ^f   Takahashi, Masatomo ^g   Shigeno, Kazuyuki ^h   Kanda, Yoshinobu ⁱ   Hatsumi, Naoko ^j   Ohtake, Shigeki ^k   Sakamaki, Hisashi ^l   Ohnishi, Kazunori ^h   Miyawaki, Shuichi ^m   Ohno, Ryuzo ⁿ   Naoe, Tomoki ^o  

^a TEIKYO UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d KINKI UNIVERSITY   (Japan)

^e GUNMA UNIVERSITY   (Japan)

^f SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^g ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ JICHI MEDICAL UNIVERSITY   (Japan)

^j SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^k KANAZAWA UNIVERSITY   (Japan)

^l TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^m Tokyo Metropolitan Ohtsuka Hospital   (Japan)

ⁿ AICHI SHUKUTOKU UNIVERSITY   (Japan)

^o NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^p NONE

more..

Author keywords

Acute myelogenous leukemia; Bacteremia fungemia; Pneumonia

Indexed keywords

AMPHOTERICIN B; COTRIMOXAZOLE; CYTARABINE; DAUNORUBICIN; ENOCITABINE; ETOPOSIDE; FLUCONAZOLE; IDARUBICIN; ITRACONAZOLE; MERCAPTOPURINE; POLYMYXIN B; PREDNISOLONE; QUINOLONE DERIVATIVE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BACTEREMIA; DISEASE ASSOCIATION; FUNGEMIA; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MORTALITY; PNEUMONIA; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; PROPHYLAXIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ADULT; BACTEREMIA; FEMALE; FUNGEMIA; HUMANS; JAPAN; LEUKEMIA, MYELOID, ACUTE; MALE; PNEUMONIA; RETROSPECTIVE STUDIES;

EID: 78751573973     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0746-y     Document Type: Article

References (32)

1. Kern WV. Current epidemiology of infections in neutropenic cancer patients. In: Rolston KVI, Rubenstein EB, editors. Textbook of febrile neutropenia. London: Martin Dunitz Ltd; 2001. p. 57-90.
2. H Wisplinghoff H Seifert RP Wenzel, et al. 2003 Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States Clin Infect Dis 36 1103 1110 10.1086/374339 12715303
3. H Link G Maschmeyer P Meyer, et al. 1994 Interventional antimicrobial therapy in febrile neutropenic patients Ann Hematol 69 231 243 1:STN:280:DyaK2M%2FjsFeqtQ%3D%3D 10.1007/BF01700277 7948312
4. G Maschmeyer H Link W Hiddemann, et al. 1994 Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study Cancer 73 2296 2304 1:STN:280:DyaK2c3itFGhtw%3D%3D 10.1002/1097-0142(19940501)73:9<2296::AID- CNCR2820730910>3.0.CO;2-7 8168033
5. S Ewig A Glasmacher B Ulrich, et al. 1998 Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy: outcome and prognostic factors Chest 114 444 451 1:STN:280:DyaK1czptlehuw%3D%3D 10.1378/chest.114.2.444 9726728
6. E Lech-Maranda M Seweryn S Giebel, et al. 2010 Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG) Int J Infect Dis 14 e132 e140 10.1016/j.ijid.2009.02.021 19581118
7. M Yoshida K Tsubaki T Kobayashi, et al. 1999 Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991 Int J Hematol 70 261 267 1:STN:280:DC%2BD3c7gslOltg%3D%3D 10643152
8. WT Hughes D Armstrong GP Bodey, et al. 1990 From the Infectious Disease Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever J Infect Dis 161 381 396 1:STN:280:DyaK3c7osl2ntQ%3D%3D 2179420
9. WT Hughes D Armstrong GP Bodey, et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever Clin Infect Dis 25 551 573 1:STN:280:DyaK2svlvVWisQ%3D%3D 10.1086/513764 9314442
10. T Masaoka 1998 Management of fever of unknown origin in the neutropenic patient: the Japanese experience Int J Hematol 68 Suppl 1 S9 S11 1:CAS:528:DyaK1MXlt1Sn 9838737
11. M Yoshida N Akiyama M Takahashi, et al. 2003 Management of infectious complications in patients with acute leukemia during chemotherapy-a questionnaire analysis by the Japan Adult Leukemia Study Group Jpn J Chemother 51 703 710 (in Japanese)
12. M Yoshida R Ohno 2004 Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey Clin Infect Dis 39 Suppl 1 S11 S14 10.1086/383044 15250015
13. WT Hughes D Armstrong GP Bodey, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 730 751 10.1086/339215 11850858
14. H Ozer JO Armitage CL Bennett, et al. 2000 Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines J Clin Oncol 18 3558 3585 1:STN:280:DC%2BD3M%2Fhsl2gsw%3D%3D 11032599
15. R Ohno T Kobayashi M Tanimoto, et al. 1993 Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. JALSG-AML87 Cancer 71 3888 3895 1:STN:280:DyaK3s3osVGjsw%3D%3D 10.1002/1097-0142(19930615)71:12<3888::AID-CNCR2820711216>3.0.CO;2-G 8508355
16. T Kobayashi S Miyawaki M Tanimoto, et al. 1996 Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia J Clin Oncol 14 204 213 1:CAS:528: DyaK28XhtVOjt7Y%3D 8558199
17. S Miyawaki M Tanimoto T Kobayashi, et al. 1999 No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group Int J Hematol 70 97 104 1:CAS:528:DyaK1MXmsFersbw%3D 10497848
18. S Ohtake S Miyawaki H Kiyoi, et al. 2010 Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study Int J Hematol 91 276 283 1:CAS:528:DC%2BC3cXivFGquro%3D 10.1007/s12185-009-0480-5 20054669
19. S Miyawaki H Sakamaki S Ohtake, et al. 2005 A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML97 study Cancer 104 2726 2734 1:CAS:528: DC%2BD28XptlSktw%3D%3D 10.1002/cncr.21493 16284985
20. T Motoji M Watanabe H Uzumaki, et al. 1991 Granulocyte colony-stimulating factor (G-CSF) receptors on acute myeloblastic leukaemia cells and their relationship with the proliferative response to G-CSF in clonogenic assay Br J Haematol 77 54 59 1:STN:280:DyaK3M7ltFyitg%3D%3D 10.1111/j.1365-2141.1991. tb07948.x 1705433
21. A Gafter-Gvili A Fraser M Paul, et al. 2005 Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients Ann Intern Med 142 979 995 15968013
22. Y Kanda R Yamamoto A Chizuka, et al. 2000 Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials Cancer 89 1611 1625 1:CAS:528: DC%2BD3cXntlSitLc%3D 10.1002/1097-0142(20001001)89:7<1611::AID-CNCR27>3.0. CO;2-B 11013378
23. A Glasmacher A Prentice M Gorschluter, et al. 2003 Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients J Clin Oncol 21 4615 4626 1:CAS:528:DC%2BD2cXpsVWqurY%3D 10.1200/JCO.2003.04.052 14673051
24. K Tamura K Imajo N Akiyama, et al. 2004 Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia Clin Infect Dis 39 Suppl 1 S15 S24 1:CAS:528: DC%2BD2cXntVahs78%3D 10.1086/383046 15250016
25. SJ Lin J Schranz SM Teutsch 2001 Aspergillosis case-fatality rate: systematic review of the literature Clin Infect Dis 32 358 366 1:STN:280:DC%2BD38%2Fgs12lsg%3D%3D 10.1086/318483 11170942
26. TF Patterson WR Kirkpatrick M White, et al. 2000 Invasive aspergillosis, disease spectrum, treatment practices, and outcomes Medicine 79 250 260 1:STN:280:DC%2BD3cvhsVGnsg%3D%3D 10.1097/00005792-200007000-00006 10941354
27. MASH Mennink-Kersten JP Donnelly PE Verweij 2004 Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis Lancet Infect Dis 4 349 357 1:CAS:528:DC%2BD2cXltlCktLg%3D 10.1016/S1473-3099(04) 01045-X 15172343
28. T Obayashi M Yoshida T Mori, et al. 1995 Plasma (1→3)-β-d- glucan determination in the diagnosis of invasive deep mycosis and fungal febrile episodes Lancet 345 17 20 1:STN:280:DyaK2M%2FpslKrsw%3D%3D 10.1016/S0140-6736(95)91152-9 7799700
29. M Kami T Fukui S Ogawa, et al. 2001 Real-time polymerase chain reaction using blood samples for diagnosis of invasive aspergillosis Clin Infect Dis 33 1504 1512 1:CAS:528:DC%2BD3MXotlKiurY%3D 10.1086/323337 11588697
30. D Caillot O Casasnovas A Bernard, et al. 1997 Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery J Clin Oncol 15 139 147 1:STN:280:DyaK2s7kvFehtQ%3D%3D 8996135
31. R Herbrecht DW Denning TF Patterson, et al. 2002 Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 408 415 1:CAS:528:DC%2BD38XlvFKrt7o%3D 10.1056/NEJMoa020191 12167683
32. TJ Walsh EJ Anaissie DW Denning, et al. 2008 Treatment of Aspergillosis: clinical practice guidelines of the Infectious Disease Society of America Clin Infect Dis 46 327 360 1:CAS:528:DC%2BD1cXitlKqt7c%3D 10.1086/525258 18177225